Ignite Creation Date:
2025-12-24 @ 1:17 PM
Ignite Modification Date:
2026-06-02 @ 7:41 AM
Study NCT ID:
NCT03937895
Status:
COMPLETED
Last Update Posted:
2022-03-29
First Post:
2019-04-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Allogeneic NK Cell ("SMT-NK") in Combination With Pembrolizumab in Advanced Biliary Tract Cancer
Sponsor:
Organization: